Alpha Teknova (TKNO) Expected to Announce Earnings on Thursday

Alpha Teknova (NASDAQ:TKNO) is expected to issue its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect Alpha Teknova to post earnings of ($0.09) per share and revenue of $9.6190 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 5:30 PM ET.

Alpha Teknova Stock Performance

NASDAQ:TKNO opened at $2.03 on Thursday. The company has a market cap of $108.66 million, a P/E ratio of -5.80 and a beta of 0.41. Alpha Teknova has a twelve month low of $1.91 and a twelve month high of $8.45. The company’s 50-day moving average price is $3.44 and its 200-day moving average price is $4.35. The company has a current ratio of 5.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.18.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in TKNO. Susquehanna International Group LLP grew its position in Alpha Teknova by 25.0% in the third quarter. Susquehanna International Group LLP now owns 16,206 shares of the company’s stock worth $100,000 after acquiring an additional 3,246 shares during the period. Larson Financial Group LLC lifted its stake in shares of Alpha Teknova by 58.5% in the 3rd quarter. Larson Financial Group LLC now owns 9,387 shares of the company’s stock valued at $58,000 after purchasing an additional 3,464 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Alpha Teknova by 123.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company’s stock worth $40,000 after purchasing an additional 4,504 shares during the period. Bridgeway Capital Management LLC increased its position in shares of Alpha Teknova by 7.9% during the 3rd quarter. Bridgeway Capital Management LLC now owns 80,900 shares of the company’s stock worth $501,000 after purchasing an additional 5,900 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Alpha Teknova in the 2nd quarter valued at about $29,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on TKNO. Weiss Ratings reissued a “sell (d-)” rating on shares of Alpha Teknova in a research note on Wednesday, January 21st. Zacks Research upgraded Alpha Teknova to a “hold” rating in a research report on Wednesday, December 10th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $8.00.

Alpha Teknova Company Profile

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.